drugset / Trial / NCT03921567

Intravenous Lidocaine for Perioperative and Postoperative Analgesia

NCT03921567 ↗

Phase 4 Unknown 520 enrolled Rajmonda Nallbani-Komoni
RandomizedFactorialDouble-blindTreatment

Summary

Postoperative pain continues to be untreated despite the application of multimodal analgesia, medication and new analgesic techniques. Traditional opioid pain treatment has many side effects, while invasive methods, such as epidural catheter, have high costs and difficulties during application. Lidocaine is a local anesthetic and its administration with intravenous routes has analgesic, antihyperalgic and antiinflammatory action. It increases the motility of the intestine and has antiemetic properties. The advantage of this method is the low cost of the preparation and its easy application. The intravenous administration of lidocaine for postoperative analgesia is recently used and not sufficiently researched technique .

Timeline

Start
2019-04-15
Primary completion
2019-10-30
Completion
2020-01-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 0.15 mg/kg Intravenous
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications